Beispiel: Heart Attack

Suchen Sie in klinischen Studien nach: Dalteparin

Insgesamt 491 ergebnisse

NCT03297359

Rekrutierung

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism

Bedingungen: Cancer; Venous Thromboembolism; Obesity
NCT00966277

Abgeschlossen

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Bedingungen: Pancreatic Cancer; Venous Thromboembolism
NCT01245998

Abgeschlossen

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis

Bedingungen: Superficial Thrombophlebitis
NCT00876915

Beendet

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Bedingungen: Venous Thromboembolism; Pulmonary Embolism
NCT02334007

Abgeschlossen

Extended Low-Molecular Weight Heparin VTE Prophylaxis in Thoracic Surgery

Bedingungen: Venous Thromboembolism; Lung Neoplasms; Pulmonary Embolism
NCT01714297

Abgeschlossen

Preoperative Versus Postoperative Start With Thromboprophylaxis in THA (Total Hip Arthroplasty)

Bedingungen: Arthritis of the Hip; Transfusion Related Complications; Infection; Wound Discharge
NCT00967382

Abgeschlossen

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study

Bedingungen: Pregnancy; Thrombophilia; Pregnancy Complications
NCT02607111

Abgeschlossen

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

Bedingungen: Kidney Failure
NCT01274637

Abgeschlossen

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot

Bedingungen: Venous Thromboembolism; Postpartum
NCT00480636

Abgeschlossen

Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients

Bedingungen: Acute Deep Vein Thrombosis
NCT00922766

Abgeschlossen

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

Bedingungen: Acute Coronary Syndrome
NCT00765063

Abgeschlossen

The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Bedingungen: Diabetic Foot Ulcer
NCT00260988

Abgeschlossen

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Bedingungen: Thromboembolism; Hemodialysis
NCT01879618

Abgeschlossen

Use Of Fragmin In Hemodialysis

Bedingungen: Chronic Renal Failure
NCT01050153

Abgeschlossen

The Clinical Utility of Thrombelastography in Guiding Prophylaxis of Venous Thromboembolism Following Trauma

Bedingungen: Venous Thromboembolism
NCT03311984

Unbekannter Status

Anti-Xa Levels in Critically Ill Patients Receiving Low-molecular-weight Heparin for Thromboprophylaxis in China

Bedingungen: Critically Ill; Anti-Xa
NCT00239980

Abgeschlossen

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Bedingungen: Ovarian Cancer
NCT03139487

Rekrutierung

A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism

Bedingungen: Cancer-associated Thrombosis; Esophageal Cancer; Stomach Cancer; Hepatocellular Carcinoma; Pancreatic Cancer; Duodenal Cancer; Esophagogastric Junction Cancer; Malignant Gastrointestinal Stromal Tumor; Ampulla of Vater Cancer; Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)
NCT00942968

Abgeschlossen

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Bedingungen: Cancer
NCT00525057

Abgeschlossen

Dalteparin in Preventing DVT in Participants With Cancer

Bedingungen: Bone Sarcoma; Femur Fracture; Lymphoma; Metastatic Neoplasm; Pathologic Fracture; Plasma Cell Myeloma; Soft Tissue Sarcoma
NCT00952380

Abgeschlossen

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Bedingungen: Venous Thromboembolism
NCT00041782

Beendet

Outpatient Treatment Of Deep Venous Thrombosis Using Subcutaneous Dalteparin (Fragmin) In Low Risk Cancer Patients

Bedingungen: Neoplasms; Deep Vein Thrombosis
NCT00432796

Aktiv, nicht rekrutierend

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Bedingungen: Stroke
NCT03593291

Unbekannter Status

LMWH-VTE Prophylaxis for Survivors of Acute Ischemic Stroke- Assessment of Standard Dosing Regimen

Bedingungen: Stroke
NCT01419977

Abgeschlossen

Treatment of Sickle Cell Patients Hospitalized in Pain Crisis With Prophylactic Dose Low-molecular-weight Heparin (LMWH) Versus Placebo

Bedingungen: Sickle Cell Disease; Vaso-occlusive Crisis